Symbol="AUTL"
AssetType="Common Stock"
Name="Autolus Therapeutics Ltd"
Description="Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T-cell therapies for the treatment of cancer. The company is headquartered in London, the United Kingdom."
CIK="1730463"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="FOREST HOUSE, 58 WOOD LANE, WHITE CITY, LONDON, GB"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="479387000"
EBITDA="-159684000"
PERatio="None"
PEGRatio="None"
BookValue="1.32"
DividendPerShare="0"
DividendYield="0"
EPS="-1.39"
RevenuePerShareTTM="0.055"
ProfitMargin="0"
OperatingMarginTTM="-22.24"
ReturnOnAssetsTTM="-0.272"
ReturnOnEquityTTM="-0.699"
RevenueTTM="7486000"
GrossProfitTTM="-130860000"
DilutedEPSTTM="-1.39"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.78"
AnalystTargetPrice="7.68"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="62.1"
PriceToBookRatio="1.046"
EVToRevenue="6.47"
EVToEBITDA="-0.118"
Beta="1.516"
num_52WeekHigh="3.77"
num_52WeekLow="1.6"
num_50DayMovingAverage="2.771"
num_200DayMovingAverage="2.296"
SharesOutstanding="173691000"
DividendDate="None"
ExDividendDate="None"
symbol="AUTL"
open="2.82"
high="2.82"
low="2.64"
price="2.78"
volume="180750.00"
latest_trading_day="2023-08-14"
previous_close="2.76"
change="0.02"
change_percent="0.7246%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="35"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="65"
Volume_recent_avg="620252"
Change_recent_avg="0.01"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="65"
Aroon_momentum_negative="35"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="1138"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0171.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="665"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0043.jpeg"
image_positive_thumbnail_id_2="614"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0094.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
